Literature DB >> 18475020

Long-term effects of antihypertensive drugs on the risk of new-onset diabetes in elderly Taiwanese hypertensives.

Yi-sheng Liou1, Tsochiang Ma, Liyun Tien, Chingwen Chien, Pesus Chou, Gwo-Ping Jong.   

Abstract

Antihypertensive drugs have been linked to new-onset diabetes (NOD); however, the effects of these drugs on the development of NOD in elderly Taiwanese hypertensive patients have not been well determined. We examined the association between antihypertensive drug therapy and the risk of NOD in a population-based study. The sample consisted of 8,638 elderly hypertensive patients. The data were obtained from claim forms provided to the central region branch of the Bureau of National Health Insurance in Taiwan from January 2001 to December 2006. Prescriptions for antihypertensive drugs before the index date were retrieved from a prescription database. We estimated the odds ratios (ORs) of NOD associated with antihypertensive drug use; nondiabetic subjects served as the reference group. The risk of NOD was higher among users of diuretics (OR, 1.12; 95% confidence interval [CI], 1.04-1.21), and beta-blockers (OR, 1.11; 95% CI, 1.02-1.20) than among nonusers. Patients who take angiotensin-converting enzyme (ACE) inhibitors (OR, 0.90; 95% CI, 0.82-0.98) or alpha-blockers (OR, 0.88; 95% CI, 0.78-0.99) are at a lower risk of developing NOD than nonusers. Angiotensin receptor blockers, calcium channel blockers, and vasodilators were not associated with risk of NOD. The results suggest that elderly hypertensive patients who take ACE inhibitors or alpha-blockers are at lower risk of NOD. Diuretics and beta-blockers were associated with a significant increase in the risk of NOD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18475020     DOI: 10.1536/ihj.49.205

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  3 in total

1.  Misclassification in assessment of diabetogenic risk using electronic health records.

Authors:  Almut G Winterstein; Paul Kubilis; Steve Bird; Rhonda M Cooper-DeHoff; Greg A Nichols; Joseph A Delaney
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-06-12       Impact factor: 2.890

2.  Effect of Yoganidra on Blood Pressure, Hs-CRP, and Lipid Profile of Hypertensive Subjects: A Pilot Study.

Authors:  J P Devraj; B Santosh Kumar; M Raja Sriswan; B Jagdish; B S Priya; S B Neelu; Vijayabhaskar Desai Rao; Manoj Kumar; J J Babu Geddam; R Hemalatha
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-30       Impact factor: 2.629

3.  Long-term Effects of Antihypertensive Drug Use and New-onset Osteoporotic Fracture in Elderly Patients: A Population-based Longitudinal Cohort Study.

Authors:  Hung-Yi Chen; Kai-Yan Ma; Pei-Ling Hsieh; Yi-Sheng Liou; Gwo-Ping Jong
Journal:  Chin Med J (Engl)       Date:  2016-12-20       Impact factor: 2.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.